Cholesterol is a fundamental molecule necessary for the maintenance of cell structure and is
vital to various normal biological functions. It is a key factor in lifestyle-related diseases …

Background The liver has a critical role in the metabolism of glucose and lipids. Chronic
hepatitis B virus (HBV) or hepatitis C virus (HCV) infection leads to a spectrum of liver …

Metabolic associated fatty liver disease (MAFLD) is the principal worldwide cause of liver
disease and affects nearly a quarter of the global population. The objective of this work was …

Obesity and associated metabolic disorders have been implicated in liver carcinogenesis;
however, there are little data on the role of obesity‐related biomarkers on liver cancer risk …

AIM To summarise the literature data on hepatitis C virus (HCV)-infected patients concerning
the prevalence of glucose abnormalities and associated risk. METHODS We conducted a …

Summary Background The World Health Organization (WHO) set a goal to eliminate
hepatitis C (HCV) infection globally by 2030, with specific targets to reduce new viral …

Early detection of cancers is challenging for lack of specific biomarkers. Adiponectin is an
adipokine predominantly derived from adipocytes and hypoadiponectinemia has been …

Background PCSK9 regulates low-density lipoprotein cholesterol (LDLc) level and has been
implicated in hypercholesterolemia. Aberrant plasma lipid profile is often associated with …

We compared hepatic and serum lipid changes in hepatocellular carcinoma (HCC) patients
to have a better understanding of the molecular pathogenesis of this disease and discovery …

Background Due to advances in interferon (IFN) therapy for chronic hepatitis C, most elderly
patients, and even many of those with advanced hepatic fibrosis, now achieve a sustained …